Patents by Inventor Karin Olsson

Karin Olsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Histidine-rich glycoprotein
    Patent number: 7205392
    Abstract: The invention relates to histidine-rich glycoprotein (HRGP) polypeptides and the use of these polypeptides. The invention includes methods for the inhibition of angiogenesis by administering an HRGP polypeptide. The invention also includes pharmaceutical compositions and articles of manufacture comprising HRGP polypeptides, antibodies and receptors that bind to an HRGP polypeptide, HRGP-depleted plasma and polynucleotides, vectors and host cells that encode HRGP polypeptides.
    Type: Grant
    Filed: February 4, 2002
    Date of Patent: April 17, 2007
    Assignee: Innoventus Project AB
    Inventors: Anna-Karin Olsson, Helena Larsson, Lena Claesson-Welsh
  • Histidine-rich glycoprotein
    Publication number: 20050042201
    Abstract: The invention relates to histidine-rich glycoprotein (HRGP) polypeptides and the use of these polypeptides. The invention includes methods for the inhibition of angiogenesis by administering an HRGP polypeptide. The invention also includes pharmaceutical compositions and articles of manufacture comprising HRGP polypeptides, antibodies and receptors that bind to an HRGP polypeptide, HRGP-depleted plasma and polynucleotides, vectors and host cells that encode HRGP polypeptides.
    Type: Application
    Filed: September 27, 2004
    Publication date: February 24, 2005
    Inventors: Anna-Karin Olsson, Helena Larsson, Lena Claesson-Welsh
  • Histidine-rich glycoprotein
    Publication number: 20020165131
    Abstract: The invention relates to histidine-rich glycoprotein (HRGP) polypeptides and the use of these polypeptides. The invention includes methods for the inhibition of angiogenesis by administering an HRGP polypeptide. The invention also includes pharmaceutical compositions and articles of manufacture comprising HRGP polypeptides, antibodies and receptors that bind to an HRGP polypeptide, HRGP-depleted plasma and polynucleotides, vectors and host cells that encode HRGP polypeptides.
    Type: Application
    Filed: February 4, 2002
    Publication date: November 7, 2002
    Inventors: Anna-Karin Olsson, Helena Larsson, Lena Claesson-Welsh